0 employees
Sollis Therapeutics is a pharmaceutical company developing non-opioid analgesic solutions.
2017
$50M
from 1 investors over 1 rounds
None raised $50M on April 12, 2018
Investors: Neurotechnology Innovations Translator (NIT)